• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The events surrounding the removal of encainide and flecainide from the Cardiac Arrhythmia Suppression Trial (CAST) and why CAST is continuing with moricizine.

作者信息

Bigger J T

机构信息

Department of Medicine, Columbia University, New York, New York 10032.

出版信息

J Am Coll Cardiol. 1990 Jan;15(1):243-5. doi: 10.1016/0735-1097(90)90209-8.

DOI:10.1016/0735-1097(90)90209-8
PMID:2104884
Abstract
摘要

相似文献

1
The events surrounding the removal of encainide and flecainide from the Cardiac Arrhythmia Suppression Trial (CAST) and why CAST is continuing with moricizine.
J Am Coll Cardiol. 1990 Jan;15(1):243-5. doi: 10.1016/0735-1097(90)90209-8.
2
Lessons from the cardiac arrhythmia suppression trial.心律失常抑制试验的经验教训。
BMJ. 1989 Sep 30;299(6703):805-6. doi: 10.1136/bmj.299.6703.805.
3
CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.心脏心律失常抑制试验（CAST）及其他。欧洲心脏病学会心律失常工作组特别工作组报告。
Circulation. 1990 Mar;81(3):1123-7. doi: 10.1161/01.cir.81.3.1123.
4
Implications of the Cardiac Arrhythmia Suppression Trial for antiarrhythmic drug treatment.心律失常抑制试验对抗心律失常药物治疗的启示
Am J Cardiol. 1990 Feb 20;65(8):3D-10D; discussion 68D-71D. doi: 10.1016/0002-9149(90)91410-8.
5
CAST and beyond. Implications of the cardiac arrhythmia suppression trials. By the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
Eur Heart J. 1990 Mar;11(3):194-9.
6
Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.恩卡胺、氟卡胺、丙咪嗪和莫雷西嗪对急性心肌梗死后一年内室性心律失常的影响：CAPS研究
Am J Cardiol. 1988 Mar 1;61(8):501-9. doi: 10.1016/0002-9149(88)90754-0.
7
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.初步报告：恩卡胺和氟卡胺在心肌梗死后心律失常抑制随机试验中对死亡率的影响
N Engl J Med. 1989 Aug 10;321(6):406-12. doi: 10.1056/NEJM198908103210629.
8
An interim perspective on the removal of encainide and flecainide from the cardiac arrhythmia suppression trial.关于从心律失常抑制试验中撤下恩卡胺和氟卡胺的中期观点。
DICP. 1989 Jun;23(6):478-9. doi: 10.1177/106002808902300609.
9
Consequences of the Cardiac Arrhythmia Suppression Trial: calamity or clarity?心律失常抑制试验的后果：灾难还是启示？
Cleve Clin J Med. 1989 Sep;56(6):649-53. doi: 10.3949/ccjm.56.6.649.
10
Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).心肌梗死患者的基线特征与恩卡尼、氟卡尼和莫雷西嗪治疗风险的相互作用。心律失常抑制试验（CAST）中死亡率增加的一种可能解释。
Circulation. 1994 Dec;90(6):2843-52. doi: 10.1161/01.cir.90.6.2843.

引用本文的文献

1
Withdrawal of prenylamine: perspectives on pharmacological, clinical and regulatory outcomes following the first QT-related casualty.心得舒的撤市：首例与QT相关的死亡事件后的药理学、临床及监管结果展望
Ther Adv Drug Saf. 2018 Jun 18;9(8):475-493. doi: 10.1177/2042098618780854. eCollection 2018 Aug.
2
Moricizine. A review of its pharmacological properties, and therapeutic efficacy in cardiac arrhythmias.
Drugs. 1990 Jul;40(1):138-67. doi: 10.2165/00003495-199040010-00007.
3
Cardiovascular therapies in the 1990s. An overview.20世纪90年代的心血管治疗。综述。
Drugs. 1991 Mar;41(3):345-57. doi: 10.2165/00003495-199141030-00003.